Timothy Wright - 01 Oct 2024 Form 4 Insider Report for AGENUS INC (AGEN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Oct 2024, 08:39:59 UTC
Prior SEC filing
01 Jul 2024
Next SEC filing
02 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Christine Klaskin as Attorney-in-Fact for Timothy R. Wright

Key filing fact

Timothy Wright filed Form 4 for AGENUS INC (AGEN) on 03 Oct 2024.

Key facts

  • This page summarizes Timothy Wright's Form 4 filing for AGENUS INC (AGEN).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 03 Oct 2024, 08:39.

Change

  • Previous filing in this sequence was filed on 01 Jul 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGEN transaction Derivative

Deferred Stock Units

Award

Transaction value
Shares
+1,252
Change %
+12%
Price
Shares after
11,671
Date
01 Oct 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,252
Exercise price
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

Footnote F2

Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

Footnote F3

$7.49 per Deferred Stock Unit acquired on October 1, 2024. The price of each Deferred Stock Unit acquired on October 1, 2024 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .